(Reuters Health) - Teens with chronic illnesses would like to have a say in decisions such as switching to a new medicine, but they often feel left out of the conversation, a small study suggests.
A Los Angeles County resident has died from a lung illness possibly tied to vaping, bringing the total number of such U.S. deaths to five, health officials said on Friday. | Video
Mallinckrodt Plc on Thursday downplayed a media report that the company had hired restructuring firms and may choose to seek bankruptcy protection.
The U.S. patent office will review patents on Alexion Pharmaceuticals Inc's blood disorder treatment Soliris, after Amgen Inc challenged them, court filings showed on Friday.
Amgen Inc will buy Celgene Corp's psoriasis drug Otezla for $13.4 billion in cash, clearing the way for Bristol-Myers Squibb to go ahead with its $74 billion deal for Celgene by the end of the year.
(Reuters Health) - As legal cannabis use becomes increasingly common in the U.S., most parents say they keep their pot out of children's reach, but fewer keep it locked away, a study in Colorado suggests.
Shares of Sarepta Therapeutics Inc plunged 14% on Tuesday after the U.S. health regulator, in an unexpected move, declined to approve the drugmaker's newest treatment for a muscle-wasting disorder that mainly affects young boys.
Aug 20 Shares of Sarepta Therapeutics Inc
plummeted 17% on Tuesday after the U.S. health
regulator, in a surprise move, declined to approve the
drugmaker's newest treatment for a muscle-wasting disorder that
mainly affects young boys.
Aug 19 Sarepta Therapeutics Inc said on
Monday the U.S. Food and Drug Administration declined to approve
its newest treatment for Duchenne muscular dystrophy (DMD),
citing safety concerns including the risk of infection and
Hospital workers often come to work with contagious respiratory illnesses, against the recommendations of public health regulators, a Canadian study suggests.